HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Buti Selected Research

Hepatitis A (Hepatitis, Infectious)

1/2001[Assessment of the PCR-Southern blot technique for the analysis of viremia in patients with acute hepatitis A].
10/2000Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)?
9/2000[Prevalence and incidence of hepatitis A in patients with hepatitis B and C].
2/2000Prospects for vaccination against hepatitis A and B in Catalonia (Spain).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Buti Research Topics

Disease

21Infections
08/2020 - 01/2001
20Chronic Hepatitis C
02/2019 - 01/2000
16Chronic Hepatitis B
01/2018 - 09/2000
9Fibrosis (Cirrhosis)
02/2019 - 01/2000
6Hepatitis B
11/2017 - 10/2000
6Hepatitis
02/2006 - 09/2000
5Hepatitis C
08/2020 - 01/2012
4Hepatocellular Carcinoma (Hepatoma)
02/2019 - 06/2011
4Hepatitis A (Hepatitis, Infectious)
01/2001 - 02/2000
3Liver Diseases (Liver Disease)
05/2014 - 11/2007
2Liver Cirrhosis (Hepatic Cirrhosis)
07/2012 - 10/2004
2Coinfection
03/2010 - 08/2001
1Liver Neoplasms (Liver Cancer)
05/2018
1Disease Progression
07/2015
1Hyperbilirubinemia
11/2014
1Hepatitis D
11/2014
1Thrombocytopenia (Thrombopenia)
11/2014
1Persistent Infection
05/2014
1HIV Infections (HIV Infection)
07/2012
1Hemolysis
01/2012
1Human Influenza (Influenza)
01/2012
1Body Weight (Weight, Body)
03/2003
1Chronic Hepatitis (Chronic Active Hepatitis)
11/2001
1Viremia
08/2001
1Anemia
04/2000

Drug/Important Bio-Agent (IBA)

14InterferonsIBA
05/2018 - 01/2000
12Ribavirin (Virazole)FDA LinkGeneric
11/2017 - 01/2000
9Lamivudine (Epivir)FDA Link
04/2015 - 04/2001
8Antiviral Agents (Antivirals)IBA
08/2020 - 11/2007
8Hepatitis B e AntigensIBA
01/2018 - 06/2005
6Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2018 - 05/2002
6RNA (Ribonucleic Acid)IBA
07/2012 - 04/2000
6DNA (Deoxyribonucleic Acid)IBA
07/2010 - 04/2001
4adefovirIBA
03/2010 - 11/2005
3Tenofovir (Viread)FDA Link
01/2018 - 11/2016
3SofosbuvirIBA
11/2017 - 01/2017
3lipoarabinomannan (LAM)IBA
04/2015 - 09/2007
3adefovir dipivoxil (Hepsera)FDA Link
07/2011 - 11/2005
2Immunoglobulin G (IgG)IBA
07/2012 - 09/2000
2Alanine Transaminase (SGPT)IBA
07/2012 - 01/2001
2peginterferon alfa-2b (Pegintron)FDA Link
03/2004 - 03/2003
2Interferon-alpha2bIBA
11/2001 - 04/2000
2Hepatitis A AntibodiesIBA
01/2001 - 09/2000
2VaccinesIBA
10/2000 - 02/2000
2AntibodiesIBA
09/2000 - 03/2000
1AntigensIBA
11/2017
1velpatasvirIBA
11/2017
1daclatasvirIBA
11/2017
1sofosbuvir drug combination ledipasvirIBA
01/2017
1Protease Inhibitors (Protease Inhibitor)IBA
01/2017
1SimeprevirIBA
01/2017
1NucleotidesIBA
01/2017
1peginterferon alfa-2a (Pegasys)FDA Link
11/2016
1alisporivirIBA
07/2015
1ButyrophilinsIBA
07/2015
1Immunoglobulins (Immunoglobulin)IBA
04/2015
1hepatitis B hyperimmune globulinIBA
04/2015
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
11/2014
1AlbuminsIBA
11/2014
1Indicators and Reagents (Reagents)IBA
05/2014
1Anti-Idiotypic AntibodiesIBA
07/2012
1Oseltamivir (Tamiflu)FDA Link
01/2012
1TelbivudineFDA Link
03/2010
1Emtricitabine (Emtriva)FDA Link
03/2010
1NucleosidesIBA
11/2007
1Transferrin (beta 2 Transferrin)IBA
10/2004
1IronIBA
10/2004
1Interferon-alpha (Interferon Alfa)IBA
09/2002
1Transaminases (Aminotransferases)IBA
05/2002
1Immunoglobulin M (IgM)IBA
01/2001
1Combined VaccinesIBA
10/2000
1A-factor (Streptomyces)IBA
10/2000
1Hepatitis C AntibodiesIBA
03/2000

Therapy/Procedure

23Therapeutics
11/2017 - 01/2000
4Liver Transplantation
02/2019 - 11/2005
1Salvage Therapy
09/2009
1Duration of Therapy
10/2000